Renal care provider InterWell Health and skincare product manufacturer Make Essence both raised approximately $46m while Salesforce-backed JazzHR agreed a merger.
Funding
InterWell Health, a US-based renal care network backed by kidney care provider Fresenius Medical Care, has completed a series B round sized at over $46m. The capital was provided by some 1,000 nephrologists representing 55 practices, and InterWell said it followed $20m in funding supplied by Fresnius and 16 nephrology practices in December 2019.
China-based men’s skincare brand Make Essence has received almost RMB300m ($46.2m) in series B-plus funding from investors including online video sharing platform Bilibli, DealStreetAsia reported…
